Alabama Widow Files Granuflo Lawsuit


Life is difficult for patients suffering from kidney failure and undergoing frequent dialysis. It seems unthinkable that someone going through this could have to face increased health risks due to a potentially dangerous medical product used during dialysis. Unfortunately, that is a reality for many renal patients who have suffered from heart attacks or other serious complications due to the use of Granuflo. Even worse, it appears that Granuflo’s manufacturer, Fresenius Medical Care, had knowledge of the increased risk of heart attack or sudden death associated with their product, but failed to notify physicians and patients properly of the risks prior to the FDA recall in 2012.

Alabama Widow Files Granuflo Lawsuit

On February 25, 2013, Tanzella Leary filed a Granuflo wrongful death lawsuit in U.S. District Court Northern District of Alabama. According to Mrs. Tanzella’s lawsuit, she alleges that her husband Darian died after suffering severe injuries and damages, including cardiovascular death, after he received the dangerous dialysis drug Granuflo. She is seeking all costs and expenses associated with her husband’s death, burial, and funeral; compensatory damages for medical expenses, and compensation for emotional distress, loss of enjoyment of life, pain and suffering. If the court deems it appropriate, she is also seeking punitive damages.

The U.S. Food and Drug Administration issued a Class I Recall for Granuflo Acid Concentrate in March 2012 based upon claims that Granuflo increases the risk of cardiac arrest by six times in kidney dialysis patients who have received the product. According to the FDA, this dry acid concentration manufactured by Germany-based Fresenius Medical Care, appears to have a higher concentration of acetate or sodium diacetate than similar products manufactured by other companies. This can lead to dangerously high serum bicarbonate concentrations in patients receiving dialysis treatment, a condition known as metabolic alkalosis. Elevated bicarbonate levels are linked to low blood pressure, cardiac arrhythmia, and other conditions that may cause cardiac arrest and even death.

If you or a loved one has suffered a heart attack or other adverse health conditions due to the use of Granuflo during kidney dialysis, you may be entitled to take legal action against the manufacturer to receive compensation for pain and suffering. Your first step before filing a lawsuit is to choose the right Granuflo lawsuit attorney to handle your case. You need an attorney who understands the technical details of Granuflo lawsuits and who will fight tenaciously to achieve a fair settlement for your injuries.

Due the complex nature of medical product defect lawsuits, it is imperative that you consult with an experienced Granuflo lawsuit attorney before taking action. While many attorneys have experience handling defective medical product cases, you should seek an attorney with specific knowledge of the technical aspects involved with Granuflo cases. The Granuflo lawsuit attorneys at Phillips Law Firm have handled countless Granuflo and other defective medical product lawsuits for clients nationwide.

If you are interested in learning more about your legal options, call us at 1-800-708-6000. Our attorneys are waiting to assist you 24/7, offering a free case evaluation. Remember our no fee promise. If we do not recover anything for you, you do not owe us an attorney fee.